Dupilumab (DPL) Improves Upper and Lower Airway Outcomes in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) with Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): Pooled Results From SINUS-24, SINUS-52 Phase 3 Trials T. Laidlaw (Boston, United States of America), J. Mullol (Barcelona, Spain), G. Canonica (Milan, Italy), C. Bachert (Ghent (Belgium) and Stockhom, Sweden), J. Han (Norfolk, United States of America), M. Zhang (Bridgewater, United States of America), X. Lu (Bridgewater, United States of America), N. Patel (Bridgewater, United States of America), N. Graham (Tarrytown, United States of America), H. Staudinger (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France), N. Amin (Tarrytown, United States of America)
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Session: Understanding, monitoring and targeting severe asthma Session type: Poster DiscussionNumber: 539
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Laidlaw (Boston, United States of America), J. Mullol (Barcelona, Spain), G. Canonica (Milan, Italy), C. Bachert (Ghent (Belgium) and Stockhom, Sweden), J. Han (Norfolk, United States of America), M. Zhang (Bridgewater, United States of America), X. Lu (Bridgewater, United States of America), N. Patel (Bridgewater, United States of America), N. Graham (Tarrytown, United States of America), H. Staudinger (Bridgewater, United States of America), L. Mannent (Chilly-Mazarin, France), N. Amin (Tarrytown, United States of America). Dupilumab (DPL) Improves Upper and Lower Airway Outcomes in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) with Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): Pooled Results From SINUS-24, SINUS-52 Phase 3 Trials. 539
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Dupilumab (DPL) Efficacy in Patients With Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) with/without Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory Disease (NSAID-ERD): SINUS-24, SINUS-52 Trials Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019
Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019
Late Breaking Abstract - First-in-Human Results of Bronchial Rheoplasty: An Endobronchial Treatment For Chronic Bronchitis (CB) Source: International Congress 2018 – Interventional pulmonology highlights in 2018: latest innovations Year: 2018
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019
Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU) Source: Sleep and Breathing Conference 2021 Year: 2021
Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
LATE-BREAKING ABSTRACT: TITLE: Hypertonic Saline in Acute Bronchiolitis: Randomised Controlled Trial (RCT) and Economic Evaluation (The SABRE Study) Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014
Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial. Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020
Clinically Meaningful Improvement in Total Rhinoconjunctivitis Score with Olopatadine/mometasone Combination Nasal Spray in Patients with Seasonal Allergic Rhinitis: A Pooled Analysis Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021
The Frequency of Small Airway Dysfunction and Its Relationship with Disease Control in Chronic Airway Diseases Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease. Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019
Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Health Outcomes of Continuous Positive Airway Pressure versus Mandibular Advancement Device for the Treatment of Severe Obstructive Sleep Apnea: an Individual Participant Data Meta-analysis Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing Year: 2021
Low Level of Airway Mucin 2 Predict Severe Exacerbations in Patients with Severe Chronic Obstructive Pulmonary Disease Source: International Congress 2017 – COPD biomarkers Year: 2017
Triple Therapy Pathways: A Multi-Country, Retrospective Observational Study in Chronic Obstructive Pulmonary Disease (COPD) Source: International Congress 2019 – Management of airway diseases in primary care Year: 2019
How to Manage Severe Asthma, the Value of Inflammation Monitoring Source: Research Seminar 2007 - Severe Asthma Year: 2007
Evaluation Of 24-Hour Day Respiratory Symptoms And GOLD Classification System In COPD Patients From Seven Latin America Countries: The LASSYC Study Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019
Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Case presentation: Advanced Physiological Monitoring during COPD Exacerbation and Nasal High-Flow Administration Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020